New Insights into HTLV-1-Related Inflammatory Diseases
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".
Deadline for manuscript submissions: 31 January 2027 | Viewed by 1051
Special Issue Editors
Interests: HTLV-1; HAM/TSP; immunology; virology; treatment; neurology
Special Issue Information
Dear Colleagues,
Human T-cell leukemia virus-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is induced by chronic inflammation in the spinal cord triggered by HTLV-1 infection. The discovery of HAM/TSP revealed that HTLV-1 has the potential to induce not only aggressive lymphoproliferation as the oncovirus leading to the development of adult T-cell leukemia (ATL), but also profound inflammatory status by immunologic activations. Indeed, there are many reports that several inflammatory diseases, such as uveitis, myositis, pulmonary disorder, arthritis, and Sjögren’s syndrome, occasionally occur in HTLV 1-infected individuals, including HAM/TSP patients. Thus, there has been an increasing awareness that HTLV-1 is a powerful inflammation causative agent. Looking into the diseases induced by HTLV-1 infection from the point of view of the inflammatory status, in this Special Issue, we aim to foster open and active discussion on the clinical and molecular characteristics, as well as therapeutic strategies, of HTLV-1-related inflammatory diseases, including HAM/TSP. We warmly invite colleagues to contribute original research articles or reviews to this Special Issue.
Dr. Tatsufumi Nakamura
Dr. Ryuji Kubota
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HTLV-1
- inflammation
- treatment
- HAM/TSP
- HTLV-1-related inflammatory status
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
